hello@mejocare.com

|

+91 8368928779

|

Become Our Partner

Home Doctors Dr. Shishir Seth

Dr. Shishir Seth

Speciality

Hematologist

Experience

25+ Years of Experience

Location

New Delhi

About Doctor

Dr. Shishir Seth is an accomplished hematologist who has been in practice for more than twenty-five years.

He treats patients suffering from acute leukemia (AML/ALL), lymphoma, multiple myeloma, chronic myeloproliferative neoplasm, myelodysplastic syndrome as well as anemia, thalassemia, bleeding, and clotting disorders.

In his career, he has performed 150 hematopoietic stem cell transplants, roughly 40% of which were allogeneic including haploidentical and antigensim mismatch transplants.

He has also performed 300 induction therapies for acute leukemia. Dr. Shishir is a member of both the Indian Society of Hematology and Transfusion Medicine and the American Society of Clinical Oncology (ASCO), as well as a member of the American Society of Hematology (ASH).

He has several publications in national and international journals, which indicate a strong interest in research.

Medical Qualifications

  • MBBS from Chaudhary Charan Singh University, Meerut in the year 1999.
  • MD in Pathology at the University of Mumbai, Mumbai in the year 2005.
  • Doctorate of Medicine (DM) in Clinical Hematology, Maharashtra University of Health Science, Nasik in the year 2009.
  • He has a Fellowship in Leukemia and Bone Marrow Transplantation (BMT) from Vancouver General Hospital, British Columbia Cancer Agency, Canada.

Clinical Expertise

Special Interest

  • Fine Needle Aspiration Cytology
  • Clinical Pathology
  • Stem Cell Transplantation
  • Cytology
  • Haemophilia
  • Childhood bone and soft tissue tumors
  • Eosinophilia Treatment
  • Biochemistry
  • Histopathology
  • Hematology

All Treatments

  • Hematological Disorders
  • Sickle Cell Disease
  • Lymphoma
  • Neuromuscular Disorders
  • Spinal Injury
  • Various Autoimmune Diseases
  • Multiple Myeloma
  • Acute Myelogenous Leukemia (AMI)
  • Orthopedic Conditions
  • Aplastic Anemia
  • Thalassemia
  • Acute Lymphocytic Leukemia
  • Congenital Neutropenia
  • Leukemia and Lymphoma
  • Sickle Cell Disease
  • Deep Vein Thrombosis
  • Hemophilia

Professional Work Experience

  • He worked as a Consultant, - For hemato-oncology & Stem Cell Transplant (BMT), at Rajiv Gandhi Cancer Institute, New Delhi ·        
  • He worked as a senior resident (DM-Clinical Hematology) at Seth G.S. Medical College & KEM Hospital, Mumbai-India.      
  • Dr Seth worked as a consultant at Moolchand Hospital, New Delhi. ·        
  • He worked as a Sr. Resident at GTB Hospital, New Delhi. ·        
  • He worked as a Clinical Assistant in hematology at PD Hinduja National Hospital, Mumbai. ·        
  • He worked as Sr. AMO at Bombay Hospital, Mumbai. ·        
  • He worked as a Junior resident at Seth G.S. Medical College & KEM Hospital, Mumbai-India.
  • Dr Seth also worked as principal investigator for 2010DRL001: An investigator-initiated observational study to evaluate the response rate and toxicity (safety) of the combination of bendamustine and rituximab (BR) in fresh adult chronic lymphocytic leukemia patients.
  • He was the Principal Investigator for IVPL_RT_01: A study of Rituximab in patients with Non-Hodgkin Lymphoma, a type of cancer.

Career Highlights

  • Dr. Shishir Seth has performed more than 300 induction therapies for acute leukemia, according to his research.
  • He performed more than 150 stem cell transplants, 40 percent of which were allogeneic and included haplo-identical and antigen mismatch transplants.

Research and Fellowships

  • Dr. Shishir Seth has many publications to his credit, including the paper “An unusual presentation of pediatric acute lymphoblastic leukemia.
  • Indian J Hematol Blood Transfus, 2008; :24(2) 59-62 “Lymph node and Tuberculosis: Clinical, Pathological and Microbiological Correlation.” In CYTOCON-2003 at Pune, India.
  • Spectrum of small intestinal lymphoma in western India” in International conference on emerging trends in hematology and immunohematology at Mumbai, India.
  • Chronic Myeloid Leukemia: Demographic and clinical profile from a tertiary center in western India
  • in Leukemias: molecular insights to treatment paradigms at Mumbai.
  • Hematopoietic Cell Transplantation in Lymphoma: Why & When; Evidence-Based Review. Cancer News, December in the year  2011;5(5) 10-12.
  • Acute Myeloid Leukemia- An Update. RGCI Newsletter-External- Mar 2012; 16(3) 2-3.
  • Autologous Stem Cell Transplantation in a patient with Burkitts Lymphoma and paraparesis.
  • Rajeeb Kumar Deo; Prakash Chitalkar; Shishir Seth, Kundan Chufal, Hilal Ahmed Yattoo, Abha Bhalla Poster presented at the 52nd Annual Meeting of the Indian Society of Hematology and Transfusion Medicine, Chandigarh, November 11-13, 2011.
  • He has a Fellowship in Leukemia and Bone Marrow Transplantation (BMT) from Vancouver General Hospital, British.

Awards and Recoginition

  • Dr. Shishir Seth has performed more than 300 induction therapies for acute leukemia, according to his research.
  • As a hematologist and hemato oncologist, he treats acute leukemia (AML/ALL), lymphoma, multiple myeloma, chronic myeloproliferative neoplasm, myelodysplastic syndrome as well as anemia, thalassemia, bleeding and clotting disorders.
  • He performed more than 150 stem cell transplants, 40 percent of which were allogeneic and included haplo-identical and antigen mismatch transplants.

How do you rate the information on this page?

5 average rating on 16 ratings

Related Doctors

Why Choose Mejocare

Enhanced Advantages
  • Patient Room Upgrade
  • Stress-Free Airport Transfers
  • Free City Tour
  • Free Teleconsultations
  • Enjoy a Complimentary Hotel Stay
  • Priority Appointments for Swift Care
  • Tailored Care to Accelerate Recovery
  • Round-the-Clock Patient Care
By Mejocare

Without Mejocare

Swipe

Still Confused?

Our care team can help you.

Contact Us

Please enter Fullname

Please enter email

Please enter email

By submitting the form I agree to the Terms of Use and Privacy Policy of Mejocare.

Submit